Profil
Philippe Martin is currently the Chief Research & Development Officer at Viatris, Inc. He previously worked as the VP-Project Leadership & Project Management at Celgene Corp from 2014 to 2016 and as the Chief Clinical Development & Operations Officer at BioAtla, Inc. from 2018 to 2023.
Mr. Martin holds an MBA from EM Lyon Business School.
Aktive Positionen von Philippe Martin
| Unternehmen | Position | Beginn |
|---|---|---|
| VIATRIS INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.12.2023 |
Ehemalige bekannte Positionen von Philippe Martin
| Unternehmen | Position | Ende |
|---|---|---|
| BIOATLA, INC. | Geschäftsführer | 01.09.2023 |
| CELGENE | Corporate Officer/Principal | 04.06.2016 |
Ausbildung von Philippe Martin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
EM Lyon Business School
EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAtla, Inc.
BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
















